Market growth is being driven by FDA approvals and successful product launches from companies like AbbVie, Pfizer, and Regeneron in the US and Italy.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22

Related events

• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• A product was launched in the U.S. market following FDA involvement.Sep 8
• Market growth for bioidentical hormones is projected to reach $5.74 billion by 2031, while the FDA monitors market trends and shortages.Sep 8
• FDA approval clears the path for drug market entry, driving future regulatory focus for major pharmaceutical companies.Aug 18
• The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.Sep 10